Gap Assessment Tool (GAT) for the NTD road map: AN INTRODUCTION - PowerPoint Presentation

1. Gap Assessment Tool (GAT) for the NTD road map: AN INTRODUCTION

2. TechnicalScientific understandingDiagnosticsEffective interventionsStrategy and service deliveryOperational and normative guidancePlanning, governance and programme managementMonitoring and evaluationAccess and logisticsHealth infrastructure and workforceEnablersAdvocacy and fundingCollaboration and multisectoral actionCapacity and awareness buildingDracunculiasisYawsEradicationLeprosyOnchocerciasisElimination(transmission)Lymphatic FilariasisSchistosomiasisTrachomaElimination(public health problem)Buruli ulcerDengueMycetomaControlNo hindrancesCritical action required

3. Disease-specific assessment Example: SchistosomiasisColour rankingDimensionCurrent statusActions requiredDiagnosticsKato–Katz and urine filtration used to measure prevalence and intensity but suboptimal in low prevalence areasMore sensitive and specific rapid diagnostic tests are being used and others are under developmentDevelop and introduce standardized, sensitive, point-of-care diagnostics for different prevalence settings and all schistosome species; use for mapping and transmission assessmentCreate biorepository of sera, urine and stool for diagnostic development, validation and evaluationDevelop test for resistance to praziquantelDevelop molecular test for xenomonitoring and surveillance(…)Monitoring and EvaluationEpidemiology of the disease currently not well understoodWorking group established to provide new guidance for M&E, granular mapping and impact assessmentImprove data quality and mapping to support target and track progress.Collect M&E data from pre-SAC, SAC and adults to inform optimal treatment strategyImplement impact assessments for potential strategy adjustmentUse endemicity data to target WASH investment (…)Capacity and awareness buildingFemale genital schistosomiasis atlas published to help in diagnostics (2015)Manual on morbidity management under developmentManual on malacology, web training platform and App under developmentManual on field use of molluscicides published (2017)Support training of health staff in laboratory diagnostics, clinical management of cases and genital manifestations, malacology and snail control.Adopt strategy for long-term sustainability and greater national ownershipRaise awareness among general public of the disease and its transmission, prevention(…)

4. The 2022 GATGreater standardisation of assessment criteria across diseases.Increased objectivity in colour ranking assessment.A specific, measurable colour rubric should be defined for each dimension.The rubric should reinforce cross-cutting approaches.The rankings should include the views of a large number of people for greater representativeness.Greater engagement with country programmes.Periodic replicationAssess the four priority dimensions (Access & Logistics, Advocacy & Funding, Diagnostics, M&E)

5. 1PublicWHO country officesGlobal online surveyCountry online survey2Disease expertsNational NTD PMWHO Regional officesWHO HQ focal pointsDisease-specific focus group discussions3Dimension expertsCountry rep.WHO NTD dept. leadDimension-specific focus group discussions4WG MERWHO Region rep.NTD Road map TeamPilot teamGAT Steering committee5WG MERWorking Group on Monitoring and EvaluationImplementation stages and participants

6. PROGRESS UPDATE

7. GLOBAL SURVEYOpen to the publicAssess fulfilment of indicators at the global level.Information on follow-up actions, current status and recommended actionsIntegrated survey results reportSTEP 1: Online surveysCOUNTRY SURVEYWHO offices where NTD are endemic.Provides country-level inputs for global level indicators (% of endemic countries that…).Information on country-level follow-up actions, current status and recommended actionsQuant. trends as % of endemic countries.Thematic analysis (status and actions)Descriptive statistics for global trendsThematic analysis (status and actions)

8. Questionnaire design for country and global surveys (completed).Translation of country and global surveys into French, Spanish, Arabic, and Portuguese (completed).Reviews of translations to check for technical terminology and homogenisation with the road map text (completed).Survey programming using Lime Survey software (completed).Functionality and content checks for all language versions (completed).Design of report template for survey data to feedback into the disease-specific FGD (completed).STEP 1: Progress update

9. STEP 1: Survey report template

10. Design of the methodological process for disease-specific FGD (completed).Identification of experts and country representatives for disease-specific FGD (ongoing).Design of the methodological process of dimension-level FGD (completed).Briefing sessions for members of disease-specific FGD (planning).Scheduling for disease-specific FGD (planning).STEP 2: Progress update

11. Integrated survey results reportSTEP 2: Disease-specific focus group discussionsColour rankingNarrow down potential colour rankingsAssess criteria fulfilmentProfileDescribe current statusRecommend critical actionsTrendsOutline justification for changes compared to previous gap assessment.GATSCReview results and confirm ranking criteria

12. NTD: [DISEASE NAME]DimensionColour rankingCurrent statusActions requiredTrendJustificationAccess and logisticsLorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas porttitor congue massa. Fusce posuere, magna sed pulvinar ultricies, purus lectus malesuada libero, sit amet commodo magna eros quis urna.Nunc viverra imperdiet enim. Fusce est. Vivamus a tellus.Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede. Mauris et orci.Advocacy and fundingLorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas porttitor congue massa. Fusce posuere, magna sed pulvinar ultricies, purus lectus malesuada libero, sit amet commodo magna eros quis urna.Nunc viverra imperdiet enim. Fusce est. Vivamus a tellus.Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede. Mauris et orci.DiagnosticsLorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas porttitor congue massa. Fusce posuere, magna sed pulvinar ultricies, purus lectus malesuada libero, sit amet commodo magna eros quis urna.Nunc viverra imperdiet enim. Fusce est. Vivamus a tellus.Monitoring and evaluationLorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas porttitor congue massa. Fusce posuere, magna sed pulvinar ultricies, purus lectus malesuada libero, sit amet commodo magna eros quis urna.Nunc viverra imperdiet enim. Fusce est. Vivamus a tellus.STEP 2: Output from disease-specific focus group discussions

13. STEP 3: Preparatory analysis: sorting colour rankings by inter-assessment trend

14. STEP 3: Preparatory work - Thematic matrix of disease-level required actions

15. Structured disease-specific assessmentSTEP 3: Dimension-level focus group discussionsRanking reviewIdentify and vote on any inconsistencies and divergences.If agreement on need for changes, re-assess colour ranking.Cross-cutting solutionsOutline dimension-level actions that can enable disease-level recommendations for each encompassing theme.TrendsCommunicate any differences of opinion to disease-specific focus group participants.Communicate outcomes to GAT-SC, including any divergent views across groups.

16. NEXT STEPS

17. Online surveys to be released the week of 12th December (TBC). Communications push to motive responses on release and again after the New Year.Data collection to be completed on 15th January.Final composition of disease-specific FGD.Final composition of the GAT Steering Committee.Scheduling of briefing sessions for disease-specific FGD members.Upcoming activities (Dec-Jan)

18. Activity202220232023DecJanuaryFebruaryMarchAprilOnline surveysSurvey data analysis and criteria review (GAT SC)Disease-specific FGDDimension FGDReview and approval disease and dimension assessmentsM&E WG approval final reportReport to STAGRevised timeline for assessment of the first 4 dimensions (TBC)